Roche taps Foundation Medicine’s chief as new North America Diagnostics lead, creates new commercial role

Dan Malarek is leaving his role as chief executive of Roche’s sequencing subsidiary Foundation Medicine as he takes up the mantle as President and CEO of Roche Diagnostics North America.